BSE filing, NSE: IFINSEC. Summary written from the filing by ALFA Finder's alert engine.
India Finsec Ltd: key numbers
- Share price
- ₹250.00
- Market cap
- ₹729.8 Cr
- Revenue (annual)
- ₹84.61 Cr
- Net profit (annual)
- ₹15.38 Cr
- P/E (TTM)
- 37.2×Sector 19.7×
- Promoter holding
- 55.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Finsec Ltd
All →India Finsec Board Meeting Date
India Finsec Ltd has scheduled its Board meeting for 30 October 2026 to approve Q1 FY27 unaudited standalone and consolidated financial results. The trading window remains closed until 48 hours post-results.
India Finsec Annual General Meeting
India Finsec Limited held its 32nd Annual General Meeting on September 29, 2026. The meeting covered adoption of financial statements and other routine business resolutions.
India Finsec Annual Report
India Finsec Limited has filed its 32nd Annual Report for the financial year 2025-26, along with the notice for the upcoming Annual General Meeting.
India Finsec Annual General Meeting
India Finsec Limited announced its 32nd Annual General Meeting will be held on September 29, 2026. The board approved meeting notices, reports, and related procedural matters.
India Finsec Q1 FY27 Results: Net Profit ₹6.9 Cr, Up 27.8% YoY
India Finsec Ltd reported revenue from operations of ₹28.5 Cr (+53.2% YoY) and net profit of ₹6.9 Cr (+27.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹6.9 Cr · +27.8% YoY
India Finsec Board Meeting Date
India Finsec Limited has scheduled a board meeting for July 30, 2026, to approve the standalone and consolidated financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.